Position in NVS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$61,676,478
+$5,669,411 QoQ
Shares Held
403,774
-0.6% QoQ
Ownership
0.021%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026ASSETMARK, INC holds $434,660,167 across 16 Drug Manufacturers - General names. NVS ranks #2 (14.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
243,853 | $85,799,678 | |
| 2 | NVS |
Novartis AG
This page
|
403,774 | $61,676,478 | |
| 3 | LLY |
ELI LILLY & Co
|
60,441 | $55,591,818 | |
| 4 | AZN |
Astrazeneca PLC
|
191,107 | $37,690,122 | |
| 5 | JNJ |
Johnson & Johnson
|
139,822 | $34,178,089 | |
| 6 | MRK |
Merck & Co., Inc.
|
232,295 | $27,942,765 | |
| 7 | GSK |
GSK plc
|
480,636 | $26,526,300 | |
| 8 | SNY |
Sanofi
|
509,464 | $24,545,975 |
All Filings in NVS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $61,676,478 | 403,774 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $56,007,067 | 406,231 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $45,929,284 | 358,151 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $38,712,067 | 319,908 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $29,981,431 | 268,940 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $25,853,515 | 265,682 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $25,764,019 | 223,996 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $22,751,140 | 213,706 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,154,560 | 218,697 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $21,839,710 | 216,299 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $20,707,424 | 203,293 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $20,057,779 | 198,769 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,277,048 | 187,794 | Shares | Defined | 2023-05-05 | |
| 2022-12-31 | $17,000,111 | 187,391 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $14,053,640 | 184,892 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $14,511,941 | 171,678 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $13,539,649 | 154,298 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $973,803 | 11,133 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $465,900 | 5,697 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $452,276 | 4,957 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $419,877 | 4,912 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $443,254 | 4,694 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $462,540 | 5,319 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $643,259 | 7,365 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $739,081 | 8,964 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||